$GDRX
GoodRx Holdings, Inc.

2021 Form 10-K Financial Statement

#000095017022002348 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $745.4M $153.5M $550.7M
YoY Change 35.36% 35.48% 41.85%
Cost Of Revenue $46.72M $9.200M $29.60M
YoY Change 57.82% 100.0% 111.43%
Gross Profit $698.7M $144.3M $521.1M
YoY Change 34.08% 32.75% 39.26%
Gross Profit Margin 93.73% 94.01% 94.63%
Selling, General & Admin $524.9M $415.7M $716.6M
YoY Change -26.75% 605.77% 273.89%
% of Gross Profit 75.12% 288.08% 137.51%
Research & Development $125.9M $23.70M $61.82M
YoY Change 103.6% 141.84% 110.98%
% of Gross Profit 18.01% 16.42% 11.86%
Depreciation & Amortization $4.000M $4.400M $1.400M
YoY Change 185.71% -44.3% 100.0%
% of Gross Profit 0.57% 3.05% 0.27%
Operating Expenses $650.8M $443.8M $778.4M
YoY Change -16.4% 508.78% 252.28%
Operating Profit $13.41M -$299.5M -$275.7M
YoY Change -104.86% -936.59% -297.4%
Interest Expense -$23.58M -$6.200M -$27.80M
YoY Change -15.17% -38.0% -43.15%
% of Operating Profit -175.91%
Other Income/Expense, Net -$23.58M $0.00 -$27.73M
YoY Change -14.96% -100.0% -51.09%
Pretax Income -$10.18M -$305.6M -$303.5M
YoY Change -96.65% -1807.26% -465.7%
Income Tax $15.08M -$7.400M -$9.827M
% Of Pretax Income
Net Earnings -$25.25M -$298.3M -$293.6M
YoY Change -91.4% -2062.5% -544.56%
Net Earnings / Revenue -3.39% -194.33% -53.32%
Basic Earnings Per Share -$0.06 -$1.07
Diluted Earnings Per Share -$0.06 -$750.3K -$1.07
COMMON SHARES
Basic Shares Outstanding 410.0M 274.7M
Diluted Shares Outstanding 410.0M 274.7M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $941.1M $968.7M $968.7M
YoY Change -2.85% 3611.49%
Cash & Equivalents $968.7M
Short-Term Investments
Other Short-Term Assets $21.31M $20.40M $20.40M
YoY Change 4.45% 64.52%
Inventory
Prepaid Expenses $17.48M
Receivables $118.1M $68.73M $68.70M
Other Receivables $8.331M $28.60M $28.60M
Total Short-Term Assets $1.089B $1.086B $1.086B
YoY Change 0.22% 1154.73% 1154.5%
LONG-TERM ASSETS
Property, Plant & Equipment $49.32M $23.06M $50.80M
YoY Change -2.92% 1139.62% 48.54%
Goodwill $261.1M
YoY Change 10.54%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.007M $2.025M $15.10M
YoY Change -60.22% 74.27% 344.12%
Total Long-Term Assets $518.8M $383.7M $383.7M
YoY Change 35.21% 27.82% 27.81%
TOTAL ASSETS
Total Short-Term Assets $1.089B $1.086B $1.086B
Total Long-Term Assets $518.8M $383.7M $383.7M
Total Assets $1.608B $1.470B $1.470B
YoY Change 9.35% 280.07% 280.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.50M $10.29M $10.30M
YoY Change 69.91% 31.08% 30.38%
Accrued Expenses $49.71M $35.40M $35.40M
YoY Change 40.44% 158.39%
Deferred Revenue $6.852M
YoY Change 98.44%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.029M $7.029M $7.000M
YoY Change 0.41% 0.0% 0.0%
Total Short-Term Liabilities $81.11M $59.55M $59.60M
YoY Change 36.1% 78.44% 78.44%
LONG-TERM LIABILITIES
Long-Term Debt $655.9M $659.9M $659.9M
YoY Change -0.61% -0.6% -0.6%
Other Long-Term Liabilities $38.73M $5.849M $39.30M
YoY Change -1.45% 96.67% -2.0%
Total Long-Term Liabilities $694.6M $665.7M $699.2M
YoY Change -0.66% -0.17% -0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.11M $59.55M $59.60M
Total Long-Term Liabilities $694.6M $665.7M $699.2M
Total Liabilities $775.9M $758.8M $758.8M
YoY Change 2.26% 2.9% 2.9%
SHAREHOLDERS EQUITY
Retained Earnings -$1.390B
YoY Change 26.77%
Common Stock $2.102B
YoY Change 23816.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $831.7M $711.4M $711.4M
YoY Change
Total Liabilities & Shareholders Equity $1.608B $1.470B $1.470B
YoY Change 9.35% 280.07% 280.07%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$25.25M -$298.3M -$293.6M
YoY Change -91.4% -2062.5% -544.56%
Depreciation, Depletion And Amortization $4.000M $4.400M $1.400M
YoY Change 185.71% -44.3% 100.0%
Cash From Operating Activities $178.8M $14.80M $131.3M
YoY Change 36.12% -55.15% 57.7%
INVESTING ACTIVITIES
Capital Expenditures $4.571M -$9.800M $20.55M
YoY Change -77.76% 226.67% 1342.32%
Acquisitions $140.3M $55.79M
YoY Change 151.41% 78.22%
Other Investing Activities -$144.3M $0.00 -$55.80M
YoY Change 158.56% -100.0% 78.27%
Cash From Investing Activities -$178.7M -$9.800M -$91.62M
YoY Change 95.09% -55.05% 147.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $7.029M $35.03M
YoY Change -79.93% -83.46%
Cash From Financing Activities -30.53M -111.4M 905.8M
YoY Change -103.37% 132.08% -1753.52%
NET CHANGE
Cash From Operating Activities 178.8M 14.80M 131.3M
Cash From Investing Activities -178.7M -9.800M -91.62M
Cash From Financing Activities -30.53M -111.4M 905.8M
Net Change In Cash 30.48M -106.4M 945.5M
YoY Change -96.78% 189.13% -11158.96%
FREE CASH FLOW
Cash From Operating Activities $178.8M $14.80M $131.3M
Capital Expenditures $4.571M -$9.800M $20.55M
Free Cash Flow $174.2M $24.60M $110.8M
YoY Change 57.24% -31.67% 35.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001809519
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
49569000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23583000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27731000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56698000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3042000
CY2021 gdrx Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
0
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 gdrx Entity Incorporation Month And Year
EntityIncorporationMonthAndYear
2015-09
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
2300000000
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39549
CY2021 dei Entity Registrant Name
EntityRegistrantName
GoodRx Holdings, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5104396
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2701 Olympic
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Boulevard
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Monica
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90404
CY2021 dei City Area Code
CityAreaCode
855
CY2021 dei Local Phone Number
LocalPhoneNumber
268-2822
CY2021 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
CY2021 dei Trading Symbol
TradingSymbol
GDRX
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
941109000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
968691000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2900000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
118080000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68729000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29638000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46048000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1088827000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1086368000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21612000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23057000
CY2021Q4 us-gaap Goodwill
Goodwill
329696000
CY2020Q4 us-gaap Goodwill
Goodwill
261116000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88791000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36919000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
44987000
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
19800000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27705000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27712000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13117000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6007000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2025000
CY2021Q4 us-gaap Assets
Assets
1607625000
CY2020Q4 us-gaap Assets
Assets
1470114000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17501000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10291000
CY2021Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
50732000
CY2020Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
37692000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7029000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7029000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5851000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4539000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81113000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
59551000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
655858000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
659888000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33592000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33467000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5138000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5849000
CY2021Q4 us-gaap Liabilities
Liabilities
775945000
CY2020Q4 us-gaap Liabilities
Liabilities
758755000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
40000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
39000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2247347000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2101773000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1415707000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1390453000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
831680000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
711359000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1607625000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1470114000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745424000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550700000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
388224000
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
46716000
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
29587000
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
14016000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125860000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61816000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29300000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
370217000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
255135000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176967000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154686000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
461451000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14692000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34539000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18430000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13573000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
732018000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
826419000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
248548000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
13406000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-275719000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
139676000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2967000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4877000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
59000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
160000
CY2019 us-gaap Interest Income Other
InterestIncomeOther
715000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
23642000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
27913000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10177000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-303450000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82978000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15077000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9827000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16930000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25254000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-293623000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
66048000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25254000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-293623000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42441000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-25254000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-293623000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42745000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
409981000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
274696000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226607000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
409981000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
274696000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231209000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1162427000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3042000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1623000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4132000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
66048000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1087582000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10831000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399722000
CY2020 gdrx Temporary Equity Value Of Shares Converted
TemporaryEquityValueOfSharesConverted
737009000
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
83575000
CY2020 gdrx Stock Issued During Period Value Charitable Stock Donation
StockIssuedDuringPeriodValueCharitableStockDonation
41721000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-293623000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
711359000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35359000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
168171000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
57955000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25254000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
831680000
CY2021 us-gaap Profit Loss
ProfitLoss
25254000
CY2020 us-gaap Profit Loss
ProfitLoss
-293623000
CY2019 us-gaap Profit Loss
ProfitLoss
66048000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34539000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18430000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13573000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4877000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3445000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3390000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3381000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3102000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
4478000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
2150000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
160462000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
397285000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3747000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2068000
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12851000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10910000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5674000
CY2021 gdrx Loss On Abandonment And Impairment Of Operating Lease Assets
LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets
1430000
CY2020 gdrx Loss On Abandonment And Impairment Of Operating Lease Assets
LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets
961000
CY2019 gdrx Loss On Abandonment And Impairment Of Operating Lease Assets
LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets
0
CY2021 gdrx Charitable Stock Donation
CharitableStockDonation
0
CY2020 gdrx Charitable Stock Donation
CharitableStockDonation
41721000
CY2019 gdrx Charitable Stock Donation
CharitableStockDonation
0
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43949000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16139000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14517000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17060000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
40935000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
102000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4207000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2154000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
515000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
14001000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
15010000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11225000
CY2021 gdrx Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-2404000
CY2020 gdrx Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
4576000
CY2019 gdrx Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-2309000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-711000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2875000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
168000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
178779000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
131341000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83286000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4571000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20553000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1425000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
140268000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
55793000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
31306000
CY2021 us-gaap Payments For Software
PaymentsForSoftware
29886000
CY2020 us-gaap Payments For Software
PaymentsForSoftware
15271000
CY2019 us-gaap Payments For Software
PaymentsForSoftware
4324000
CY2021 gdrx Investment In Minority Equity Interest
InvestmentInMinorityEquityInterest
4008000
CY2020 gdrx Investment In Minority Equity Interest
InvestmentInMinorityEquityInterest
0
CY2019 gdrx Investment In Minority Equity Interest
InvestmentInMinorityEquityInterest
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-178733000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91617000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37055000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
891793000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
100000000
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
28000000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
154613000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7029000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
35029000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
211845000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1306000
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2214000
CY2021 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
832000
CY2020 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1623000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4937000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35021000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5343000
CY2020 gdrx Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
667000
CY2019 gdrx Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
0
CY2021 gdrx Employee Taxes Paid Related To Net Share Settlement Of Equity Awards
EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards
57688000
CY2020 gdrx Employee Taxes Paid Related To Net Share Settlement Of Equity Awards
EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards
78714000
CY2019 gdrx Employee Taxes Paid Related To Net Share Settlement Of Equity Awards
EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards
0
CY2020 gdrx Noncash Capitalized Software Development Costs In Accrued Expenses And Other
NoncashCapitalizedSoftwareDevelopmentCostsInAccruedExpensesAndOther
1273000
CY2019 gdrx Noncash Capitalized Software Development Costs In Accrued Expenses And Other
NoncashCapitalizedSoftwareDevelopmentCostsInAccruedExpensesAndOther
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30528000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
905817000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54781000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30482000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
945541000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8550000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
971591000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26050000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34600000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
941109000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
971591000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26050000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
18105000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
29228000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
19400000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
20198000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
24517000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
48443000
CY2021 gdrx Noncash Purchase Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
NoncashPurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
0
CY2020 gdrx Noncash Purchase Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
NoncashPurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
2100000
CY2019 gdrx Noncash Purchase Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
NoncashPurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
0
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2910000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
234000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29493000
CY2021 gdrx Noncash Stock Based Compensation Included In Capitalized Software
NoncashStockBasedCompensationIncludedInCapitalizedSoftware
7709000
CY2020 gdrx Noncash Stock Based Compensation Included In Capitalized Software
NoncashStockBasedCompensationIncludedInCapitalizedSoftware
2437000
CY2019 gdrx Noncash Stock Based Compensation Included In Capitalized Software
NoncashStockBasedCompensationIncludedInCapitalizedSoftware
385000
CY2021 gdrx Noncash Capitalized Software Development Costs In Accrued Expenses And Other
NoncashCapitalizedSoftwareDevelopmentCostsInAccruedExpensesAndOther
1086000
CY2021 gdrx Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering
ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering
0
CY2020 gdrx Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering
ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering
737009000
CY2019 gdrx Conversion Of Preferred Stock To Common Stock In Connection With Initial Public Offering
ConversionOfPreferredStockToCommonStockInConnectionWithInitialPublicOffering
0
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
941109000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
968691000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26050000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2900000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
941109000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
971591000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26050000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">Use of Estimates</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements, including the accompanying notes. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ materially from these estimates, and such differences could affect the results of operations reported in future periods. The Company bases its estimates on historical factors, current circumstances, the experience and judgment of management and includes consideration of the economic impact of the COVID-19 pandemic. The Company’s prescription transactions offering experienced a decline in activity at the onset of the pandemic in the second quarter of 2020 as many consumers avoided visiting healthcare professionals and pharmacies in-person, though beginning in the third quarter of 2020 activity in the Company’s prescription transactions </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">offering improved. The full extent to which the COVID-19 pandemic will impact the Company's business, results of operations and financial condition is still unknown and will depend on future developments, which are highly uncertain and cannot be predicted. As the impact of the COVID-19 pandemic continues to develop, many of the Company’s estimates could require increased judgment and carry a higher degree of variability and volatility, and may change materially in future periods.</span></p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">Certain Risks and Concentrations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;"> </span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents and accounts receivable. The Company maintains cash deposits with multiple financial institutions in the United States which, at times, may exceed federally insured limits. Cash may be withdrawn or redeemed on demand. The Company believes that the financial institutions that hold its cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company has not experienced any losses in such accounts.</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Company extends credit to its customers based on an evaluation of their ability to pay amounts due under contractual arrangements and generally does not obtain or require collateral.</span></p><p style="text-indent:1.867%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">For the year ended December 31, 2021, two customers accounted for</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> approximately </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% and </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">of the Company’s revenue. At December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">, </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> customers accounted for more than </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% of the Company’s accounts receivable balance. For the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">December 31, 2020,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">customers accounted for</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> approximately </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">%, </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% and </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">of the Company’s revenue. At December 31, 2020,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">customer accounted for </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> of the Company’s accounts receivable balance. For the year ended December 31, 2019,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">customers accounted for</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> approximately </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% and </span><span style="font-size:10.0pt;font-family:Arial;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">23</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">of the Company’s revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span></p>
CY2021 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Depreciation is computed using the straight-line method over the estimated useful lives of the assets
CY2021Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.20
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2020 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2019 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745424000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550700000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
388224000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
296600000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
222400000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
163700000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2021 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
1070000000.00
CY2021 gdrx Equity Securities Held By Non Affiliates
EquitySecuritiesHeldByNonAffiliates
700000000.0
CY2021 gdrx Non Convertible Debt Securities
NonConvertibleDebtSecurities
1000000000.0
gdrx Equity Securities Held By Non Affiliates
EquitySecuritiesHeldByNonAffiliates
700000000.0
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8331000
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
28564000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21307000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17484000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29638000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46048000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27441000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25187000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5829000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2130000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21612000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23057000
CY2021 us-gaap Depreciation
Depreciation
4000000.0
CY2020 us-gaap Depreciation
Depreciation
1400000
CY2019 us-gaap Depreciation
Depreciation
700000
CY2020Q4 us-gaap Goodwill
Goodwill
261116000
CY2019Q4 us-gaap Goodwill
Goodwill
236225000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
68580000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
24891000
CY2021Q4 us-gaap Goodwill
Goodwill
329696000
CY2020Q4 us-gaap Goodwill
Goodwill
261116000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
157114000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
68323000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88791000
CY2021 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y10M24D
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
90209000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53290000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36919000
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18300000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12700000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11200000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
16562000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12872000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8296000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7338000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
7017000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
36706000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88791000
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
63752000
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
26344000
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
18765000
CY2020Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
6544000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
44987000
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
19800000
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
12200000
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4400000
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1700000
CY2021Q4 gdrx Capitalized Software Costs Not Ready For Intended Use
CapitalizedSoftwareCostsNotReadyForIntendedUse
4800000
CY2021Q4 gdrx Capitalized Computer Software Expected Amortization Year One
CapitalizedComputerSoftwareExpectedAmortizationYearOne
17901000
CY2021Q4 gdrx Capitalized Computer Software Expected Amortization Year Two
CapitalizedComputerSoftwareExpectedAmortizationYearTwo
15281000
CY2021Q4 gdrx Capitalized Computer Software Expected Amortization Year Three
CapitalizedComputerSoftwareExpectedAmortizationYearThree
6997000
CY2021Q4 gdrx Capitalized Computer Software Expected Amortization
CapitalizedComputerSoftwareExpectedAmortization
40179000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5600000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
7000000.0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
3000000.0
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6200000
CY2021 gdrx Lease Incentive Receivables Current
LeaseIncentiveReceivablesCurrent
1600000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3000000.0
CY2020 gdrx Lease Incentive Receivables Current
LeaseIncentiveReceivablesCurrent
5700000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2500000
CY2021Q4 gdrx Accrued Bonus And Other Payroll Related Current
AccruedBonusAndOtherPayrollRelatedCurrent
24031000
CY2020Q4 gdrx Accrued Bonus And Other Payroll Related Current
AccruedBonusAndOtherPayrollRelatedCurrent
13607000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
15493000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10045000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6869000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6852000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4339000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7188000
CY2021Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
50732000
CY2020Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
37692000
CY2021 gdrx Noncancellable Operating Lease Expiry Year
NoncancellableOperatingLeaseExpiryYear
2033
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Certain of the Company’s facility leases contain renewal options for periods of up to 10 years, at the Company’s election.
CY2021Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5851000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5639000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5689000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5865000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5120000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
22846000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51010000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11567000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
39443000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5851000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33592000
CY2021Q2 gdrx Lease Expiration Year
LeaseExpirationYear
2033
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
41400000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-361000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
235000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
20012000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2532000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
848000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2592000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
2171000
CY2020 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
1083000
CY2019 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
22604000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6521000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7472000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4670000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
6385000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3438000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1004000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
12906000
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-10910000
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-5674000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15077000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9827000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16930000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2137000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-63725000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
17425000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
8385000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2768000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
988000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
491000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
609000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
313000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-43797000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-19961000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-788000
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
8206000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3541000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
1661000
CY2021 gdrx Income Tax Reconciliation Nondeductible Officers Compensation
IncomeTaxReconciliationNondeductibleOfficersCompensation
21905000
CY2020 gdrx Income Tax Reconciliation Nondeductible Officers Compensation
IncomeTaxReconciliationNondeductibleOfficersCompensation
79046000
CY2019 gdrx Income Tax Reconciliation Nondeductible Officers Compensation
IncomeTaxReconciliationNondeductibleOfficersCompensation
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
37782000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-293000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
380000
CY2021 gdrx Effective Income Tax Rate Reconciliation Transaction Cost
EffectiveIncomeTaxRateReconciliationTransactionCost
438000
CY2020 gdrx Effective Income Tax Rate Reconciliation Transaction Cost
EffectiveIncomeTaxRateReconciliationTransactionCost
277000
CY2019 gdrx Effective Income Tax Rate Reconciliation Transaction Cost
EffectiveIncomeTaxRateReconciliationTransactionCost
242000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
216000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
529000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
31000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15077000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9827000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16930000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.481
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5072000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2303000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction
DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction
9702000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction
DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction
8747000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10097000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4422000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
19407000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4146000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
580000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
296000
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
4699000
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
8817000
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
8403000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
8668000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
9329000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21907000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
215000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
88949000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
37861000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52679000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
268000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
36270000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
37593000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-527000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-825000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6727000
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
4557000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
13635000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6377000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4699000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4621000
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
10926000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
8096000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
36514000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24476000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
244000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
13117000
CY2021Q4 gdrx Income Tax Expense Valuation Allowance Recognized
IncomeTaxExpenseValuationAllowanceRecognized
52400000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
65300
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4509000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
879000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
744000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4374000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
126000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3327000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
119000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
317000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7391000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
999000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6911000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
505000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14796000
CY2021Q4 gdrx Reversal Of Uncertain Benefits
ReversalOfUncertainBenefits
9700000
CY2021Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
1700
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000000.0
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000000.0
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3300000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7029000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7029000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7029000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
653010000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
674097000
CY2021 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2024-10-11
CY2021 gdrx Line Of Credit Facility Fixed Fronting Fee Percentage
LineOfCreditFacilityFixedFrontingFeePercentage
0.00125
CY2021Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
3300000
CY2021Q2 gdrx Number Of Lawsuits
NumberOfLawsuits
2
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021 us-gaap Common Stock Conversion Features
CommonStockConversionFeatures
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder and will automatically convert to Class A Common Stock upon any transfer, except for certain permitted transfers. All Class B Common Stock will convert automatically into an equivalent number of Class A Common Stock upon the earlier of (i) September 25, 2027; or (ii) the first date the aggregate number of shares of Class B Common Stock cease to represent at least 10% of the aggregate outstanding shares of common stock. During the years ended December 31, 2021 and December 31, 2020, 13.1 million and 28.7 million shares of Class B Common Stock were converted into an equivalent number of shares of Class A Common Stock, respectively.
CY2021 gdrx Minimum Percentage Of Aggregate Outstanding Shares Of Common Stock To Be Cease
MinimumPercentageOfAggregateOutstandingSharesOfCommonStockToBeCease
0.10
CY2020 gdrx Stock Issued During Period Value Charitable Stock Donation
StockIssuedDuringPeriodValueCharitableStockDonation
41700000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.81
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.23
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.27
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
244400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
112700000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11100000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
15300000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
10200000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2500000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.009
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.014
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.014
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.024
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.575
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.60
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.50
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.62
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2019 gdrx Payment Of Cash Bonus To Vested Option Holders
PaymentOfCashBonusToVestedOptionHolders
3880
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25254000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-293623000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-293623000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
66048000
CY2021 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2020 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2019 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
23607000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25254000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42441000
CY2021 gdrx Undistributed Earnings Loss Reallocated To Common Shareholders Diluted
UndistributedEarningsLossReallocatedToCommonShareholdersDiluted
0
CY2020 gdrx Undistributed Earnings Loss Reallocated To Common Shareholders Diluted
UndistributedEarningsLossReallocatedToCommonShareholdersDiluted
0
CY2019 gdrx Undistributed Earnings Loss Reallocated To Common Shareholders Diluted
UndistributedEarningsLossReallocatedToCommonShareholdersDiluted
304000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-25254000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-293623000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42745000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
409981000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
274696000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226607000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4602000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
409981000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
274696000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231209000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
0
CY2020 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
0
CY2019 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
0
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1623000

Files In Submission

Name View Source Status
0000950170-22-002348-index-headers.html Edgar Link pending
0000950170-22-002348-index.html Edgar Link pending
0000950170-22-002348.txt Edgar Link pending
0000950170-22-002348-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gdrx-20211231.htm Edgar Link pending
gdrx-20211231.xsd Edgar Link pending
gdrx-20211231_cal.xml Edgar Link unprocessable
gdrx-20211231_def.xml Edgar Link unprocessable
gdrx-20211231_htm.xml Edgar Link completed
gdrx-20211231_lab.xml Edgar Link unprocessable
gdrx-20211231_pre.xml Edgar Link unprocessable
gdrx-ex21_1.htm Edgar Link pending
gdrx-ex23_1.htm Edgar Link pending
gdrx-ex31_1.htm Edgar Link pending
gdrx-ex31_2.htm Edgar Link pending
gdrx-ex31_3.htm Edgar Link pending
gdrx-ex32_1.htm Edgar Link pending
gdrx-ex32_2.htm Edgar Link pending
gdrx-ex32_3.htm Edgar Link pending
img95031654_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending